Pith. sign in

REVIEW 3 major objections 5 minor 69 references

Targeting Cholangiocarcinoma Cells By Cold Piezoelectric Plasmas: In Vitro Efficacy And Cellular Mechanisms

T0 review · 3 major / 5 minor · reviewed 2026-08-11 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Cold piezoelectric plasma kills cholangiocarcinoma cells in culture by activating a DNA-damage-linked apoptosis pathway, without altering cell membrane permeability.

desk verdict A solid first application of piezoelectric plasma to cholangiocarcinoma with careful physics characterization, but the missing helium-only control and large medium evaporation leave the apoptosis mechanism unproven. read the letter →

arxiv 2412.09761 v1 pith:6DDHQPTS submitted 2024-12-12 physics.plasm-ph

Manon Soulier , Bouchra Lekbaby , Imane Houari , Henri Decauchy , Allan Pavy , Alexia Coumes , Romain Morichon , Thierry Dufour
show 1 more author
Laura Fouassier
This is my paper · ORCID
classification physics.plasm-ph PACS 52.80.-s52.70.Kz
keywords coldpiezoelectricplasmacholangiocarcinomacoronadischargedielectricbarrierreactiveoxygenandnitrogenspeciesDNAdamageresponseapoptosisactincytoskeleton
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper sets out to show that cold piezoelectric plasma—generated by a hand-sized device in either corona or dielectric-barrier mode—can kill human cholangiocarcinoma cells in vitro. It reports that both modes reduce viability of two bile-duct cancer cell lines 24 hours after a few minutes of exposure, and that the cell death has the hallmarks of apoptosis triggered by a DNA damage response: γH2AX foci, phosphorylation of Chk1 and p53, and cleavage of caspase-3 and PARP. The same treatment rearranges the actin cytoskeleton within minutes but does not make the membrane permeable to a small fluorescent dye, pointing to intracellular oxidative signaling rather than electroporation as the route of killing. If the results hold, cold piezoelectric plasma would be a compact and potentially endoscopic tool for treating an aggressive cancer that currently has limited curative options.

What carries the argument

The central object is the cold piezoelectric plasma source, a lead-zirconate-titanate transformer that generates kilovolt-level discharges in either a corona configuration (Pz-CD) or a dielectric-barrier configuration (Pz-DBD) with a helium flow driver. The mechanism that carries the biological argument is the plasma-liquid transfer of reactive species: both modes raise nitrite and hydrogen peroxide in the culture medium to hundreds of micromolar concentrations, and the paper links these to the later DNA damage response and apoptosis. The immediate cytoskeletal readout uses phalloidin labeling of F-actin, and the membrane-integrity readout uses YO-PRO-1, a 630 Da cell-impermeant dye; together these two assays separate the electric-field hypothesis from the oxidative-signaling hypothesis.

What would settle it

Expose HuCCT-1 and EGI-1 cells to helium at the same flow rates and for the same durations as the plasma treatments, with the plasma switched off, and measure viability, γH2AX, and apoptosis markers at 0 and 24 hours; if the helium-only control reproduces the viability loss or DNA-damage response, the central attribution of cell death to CPP-generated reactive species is falsified.

Watch

Extended reading notes

Core claim

On the paper's own terms, the central discovery is that cold piezoelectric plasma is effective against cholangiocarcinoma cells in vitro through a specific intracellular pathway. The two discharge modes differ in power and thermal footprint—Pz-CD deposits about five times more power and heats the medium more, while Pz-DBD produces a more uniform cell-layer effect—yet both converge on the same molecular endpoint: DNA double-strand-break signaling (γH2AX), activation of Chk1 and p53, and the execution of apoptosis as shown by cleaved caspase-3 and cleaved PARP. Viability falls dose-dependently with exposure time, with IC50 reached between 2 and 3 minutes for HuCCT-1 cells and between 3 and 5 minutes for EGI-1 cells. The immediate, non-lethal arm of the response is a reorganization of F-actin into stress fibers and membrane protrusions in HuCCT-1 cells and shape changes in EGI-1 cells, observed without uptake of a cell-impermeant dye. The authors therefore conclude that CPP acts without disrupting membrane integrity.

Load-bearing premise

The argument that plasma-generated reactive species cause the cell death assumes that the helium gas flow and the up to 20% loss of medium by evaporation do not themselves damage the cells; the paper reports no helium-only, no-plasma control, so this premise is unverified.

Editorial extensions

If this is right

  • A few minutes of exposure to either plasma mode reduces viability of HuCCT-1 and EGI-1 cholangiocarcinoma cells by up to about 75% at 5 min, with IC50 reached in 2–5 min depending on cell line and mode.
  • Cell death is executed through the DNA damage response: γH2AX, pChk1, and pp53 rise after treatment, followed by cleaved caspase-3 and cleaved PARP.
  • Plasma does not permeabilize the cell membrane, so cytotoxic action is intracellular and likely mediated by plasma-generated reactive species in the medium.
  • Pz-CD produces a spatially localized and more powerful effect while Pz-DBD is more uniform, which could allow mode selection according to the geometry of the target tissue.
  • Medium evaporation rises linearly with exposure time to about 20% after 5 min, so dosing protocols must account for volume loss and concentration of solutes.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If the attribution to reactive species is right, then the same hand-held source could be coupled to an endoscopic applicator to treat biliary duct tumors in situ; the paper's companion feasibility work on cold plasma endoscopy makes this a natural next step.
  • The lack of a helium-only, no-plasma control means the gas flow and the ~20% evaporation could, in principle, contribute to the observed viability loss; adding such a control would cleanly test the reactive-species hypothesis.
  • Because Pz-CD reaches higher nitrite levels than Pz-DBD at 5 min and EGI-1 cells are more sensitive to Pz-CD, one could test the causal role of nitrite by spiking untreated medium with matched nitrite concentrations.
  • The immediate actin remodeling without membrane permeabilization suggests the cytoskeleton may respond to oxidative or thermal signaling rather than electroporation; using an actin polymerization inhibitor would test whether cytoskeletal change is necessary for later apoptosis.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 5 minor

Summary. The paper reports an in vitro study of cold piezoelectric plasmas (CPP) on two cholangiocarcinoma cell lines (HuCCT-1 and EGI-1). The authors characterize the electrical, chemical, and thermal properties of two discharge configurations (corona, Pz-CD; dielectric barrier, Pz-DBD), quantify medium evaporation, and assess immediate and 24-h effects on cell layers, viability, DNA damage response (γH2AX, pChk1, pp53), apoptosis markers (cleaved caspase-3, cleaved PARP), antioxidant gene expression, membrane permeability, and actin cytoskeleton. The central claim is that CPP activates a DNA damage response leading to apoptosis, without permeabilizing the cell membrane, and that this is mediated by plasma-generated reactive species rather than by physical perturbations.

Significance. The paper is the first to evaluate piezoelectric cold plasma on cholangiocarcinoma cells, a cancer with limited therapeutic options. Its strengths include careful electrical and chemical characterization of the plasma-liquid interaction, spatial and temporal thermal mapping, and the use of multiple molecular endpoint assays (immunofluorescence, western blot, RT-qPCR) with standard statistical reporting. The portability of the device is a practical advantage. However, the causal interpretation of the biological data is not fully secured because the manuscript lacks a helium-only (no plasma) control and does not account for the large medium evaporation as a biological confound. If these issues are addressed, the paper would provide a useful foundation for further plasma oncology studies.

major comments (3)
  1. [Section 4.5 and Fig. 2d] The absence of a helium-only (no plasma) control and the lack of an evaporation-matched sham condition leave the central causal claim unsecured. Fig. 2d shows up to 20% wt of medium lost immediately and 40% after 24 h for 5-min CPP exposure; this raises solute concentration and osmolality by roughly 20–25%, and the treated medium is left on the cells for the full 24-h incubation. The 0-min condition is not defined as including helium flow, so the observed viability loss, γH2AX foci, and apoptosis markers could in part reflect hyperosmotic/gas-flow stress rather than plasma-generated reactive species. The authors should add a helium-only control (same flow rates without plasma) and, ideally, an evaporation-matched control (e.g., replenishing evaporated water or adjusting osmolality) for the viability and DDR assays.
  2. [Fig. 3b and Fig. 4a] The immediate loss of HuCCT-1 cells after 3-5 min Pz-CD exposure (Fig. 3b) indicates physical cell detachment, yet the 24-h viability assay (Fig. 4a) and apoptosis markers are presented as evidence of a single cell-death pathway. Because detached cells are typically excluded from crystal violet and western blot assays, the 24-h 'efficacy' for Pz-CD on HuCCT-1 may overstate apoptosis while understating immediate physical killing. The authors should quantify cell detachment immediately after treatment (e.g., counting cells in the supernatant, or live/dead staining at 0 h) and discuss how this affects the viability and apoptosis data.
  3. [Fig. 1f and Fig. 4c] The attribution of the DNA damage response and apoptosis to reactive species is inferential. Although nitrite and H2O2 production in the medium is demonstrated (Fig. 1f), no experiments with scavengers (e.g., catalase, N-acetylcysteine) or with plasma-activated medium alone are provided. Such experiments would test whether the observed γH2AX/pChk1/pp53 activation and cleaved caspase-3/PARP induction are specifically mediated by plasma-generated ROS/RNS, rather than by transient electric fields, heating, or evaporation-related stress.
minor comments (5)
  1. [Section 4.5] Please define the 0-min condition explicitly: does it include helium flow without plasma for the same duration as the treated groups, or is it an untreated control? This is important for interpreting the dose-response data.
  2. [Fig. 2d] The y-axis label '%wt' should be defined in the figure caption; please specify whether it is weight percent loss relative to the initial medium weight.
  3. [Fig. 4a] The text mentions 'survival regressions' for the viability data, but the curve-fitting model and R2 values are not reported; please provide these details.
  4. [Section 3 (Discussion)] The sentence 'While with Pz-DBD, most enzyme expression is up-regulated; unexpectedly, it is not the case for Pz-CD' would be clearer as 'with Pz-DBD most antioxidant enzymes are up-regulated, whereas with Pz-CD only HMOX1 is increased.'
  5. [References] Reference [9] (Laroussi) is a preprint; please cite the published version if available.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: the paper's central claims are supported by direct experimental measurements, with only non-load-bearing methodological self-citations.

full rationale

The paper is an experimental study without fitted parameters, predictive equations, or derived quantities. The central claim that cold piezoelectric plasma reduces HuCCT-1 and EGI-1 viability and triggers γH2AX/pChk1/pp53, cleaved caspase-3, and cleaved PARP is based on direct measurements: crystal violet absorbance, immunofluorescence, western blots, and RT-qPCR. These readouts are external to the definition of the plasma treatment and are not constructed from any fitted input. The only self-citations are methodological: ref. [40] (Judée & Dufour) supplies the human-body-impedance target used for electrical characterization, and ref. [19] (Vaquero et al.) is cited for antibody validation; neither is load-bearing for the biological conclusion, and neither defines the outcome variables. The absence of a helium-only or evaporation-matched sham is a genuine experimental-control limitation for causal attribution to reactive species, but it is a confound, not a circular reduction: it does not make any measured endpoint equivalent to the treatment input by construction. Accordingly, no circular step is identified.

Assumptions & free parameters 2 free parameters · 5 assumptions · 0 invented entities

The study introduces no new fitted constants or postulated entities. The quantitative claims rest on measured concentrations, temperatures, and assay readouts. The only hand-chosen parameters are the operating conditions of the plasma device (liquid volume, helium flow rate), which are fixed per protocol and not fitted to the results.

free parameters (2)
  • Culture medium volume = 1.2 mL (Pz-DBD), 1.4 mL (Pz-CD)
    Chosen in Section 4.1 to optimize the treatments; differs between configurations, so the two plasma sources are not compared under identical liquid geometry.
  • Helium flow rate = 0.4 slm (Pz-DBD), 0.5 slm (Pz-CD)
    Set in Section 4.1 to enable corona ignition and confine the gas mixture; hand-chosen operating conditions that influence evaporation and mixing.
assumptions (5)
  • domain assumption YO-PRO-1 dye (630 Da) does not penetrate intact cell membranes; used as a cell-impermeant permeability probe.
    Invoked in Section 4.10 to interpret absence of dye uptake as absence of membrane permeabilization; relies on standard dye properties established in prior literature.
  • domain assumption GammaH2AX phosphorylation marks DNA double-strand breaks and is a valid proxy for DNA damage response.
    Used in Section 2.4 to conclude CPP induces DNA damage; standard assay assumption, not justified within this paper.
  • domain assumption Crystal violet absorbance is proportional to the number of viable, adherent cells.
    Used in Section 4.6 to measure viability 24 h after treatment; a standard assay assumption.
  • domain assumption The RC electric target (RT=1.5 kOhm, CT=100 pF) approximates human body impedance for plasma electrical characterization.
    Used in Section 4.3 and Fig. 1d to report deposited power; adopted from the authors' earlier work (ref 40).
  • domain assumption Temperatures below 40 degrees C do not by themselves cause cell damage in these conditions.
    Invoked in the Discussion (Section 3) to argue thermal effects are not cytotoxic; based on reference 54.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Targeting Cholangiocarcinoma Cells By Cold Piezoelectric Plasmas: In Vitro Efficacy And Cellular Mechanisms." pith.science (2026). https://pith.science/paper/6DDHQPTS

@misc{pith2026241209761,
  author       = {Pith},
  title        = {Pith review of: Targeting Cholangiocarcinoma Cells By Cold Piezoelectric Plasmas: In Vitro Efficacy And Cellular Mechanisms},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/6DDHQPTS}},
  note         = {Machine review of arXiv:2412.09761}
}
read the original abstract

Cold piezoelectric plasma (CPP) is a novel approach in cancer therapy, enabling the development of portable treatment devices capable of triggering cancer cell death. While its effectiveness remains underexplored, this research focuses on its application against cholangiocarcinoma (CCA), an aggressive cancer of the biliary tract. A CPP device is utilized to generate either a corona discharge (Pz-CD) or a dielectric barrier discharge (Pz-DBD) for in vitro experiments. Notably, Pz-CD can deliver more power than Pz-DBD, although both sources produce significant levels of reactive species in plasma and liquid phases. This work shows that CPP causes a gradient increase in medium temperature from the center towards the edges of the culture well, especially for longer treatment times. Although Pz-CD heats more significantly, it cools quickly after plasma extinction. When applied to human CCA cells, CPP shows immediate and long-term effects, more localized for Pz-CD, while more uniform for Pz-DBD. Immediate effects result also in actin cytoskeleton remodeling without alteration of the cell membrane permeability. Long-term effects of CPP, although the antioxidant system is engaged, include activation of the DNA damage response pathway leading to cell death. In conclusion, CPP should be recognized as a promising antitumor therapy.

Figures

Figures reproduced from arXiv: 2412.09761 by the authors.

Figure 1
Figure 1. Cold piezoelectric plasma (CPP) device, electric and chemical properties. (a) Photograph of the commercial source of p [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 2
Figure 2. Localized thermal effects induced by CPP. (a) 3D [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 5
Figure 5. Effect of CPP on cell membrane permeability and actin cytoskeleton. Representative immunofluorescence images of (a) cell impermeant dye and (b) F-actin cytoskeleton in CCA cells captured immediately after Pz-DBD exposure for 0.5, 1, 2, 3 and 5 min. (a) Cell impermeant dye does not cross the cell membrane of CCA cells treated with Pz-DBD compared to cells treated with Triton X-100, a detergent that induces pores in t… view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

69 extracted references · 63 canonical work pages

  1. [1]

    Introduction Cancer is a leading cause of death worldwide (incidence: 20 million – mortality: 10 million in 2020 [1]). While progress has been made in detecting and treating common cancers like breast and prostate, rare and aggressive cancers like cholangiocarcinoma (CCA) are facing high mortality rates and increasing incidence worldwide [1], [2]. CCA, co...

    2024

  2. [2]

    plasma ON

    Results 2.1. Electrical and chemical properties of cold piezoelectric plasma First, an electrical characterization of the CPP (Fig. 1a), either in Pz- DBD (Fig. 1b) or Pz-CD (Fig. 1c) configuration is realized, followed by an analysis of the reactive species produced in both plasma and liquid phases. As far as the distribution of electric field lines from...

    2024

  3. [3]

    Air Plasma Activated Media

    Discussion The present work investigates the effects of two cold piezoelectric plasma (CPP) sources in the purpose of cancer therapy, using human cholangiocarcinoma (CCA) cells as in vitro models. CCA is a rare cancer of the biliary tract that displays high mortality rates and increasing incidence, without other curative treatment than tumor resection for...

    2024

  4. [4]

    Cold piezoelectric plasma device and exposure conditions Plasma device: the piezobrush® PZ2 ( Fig

    Methods 4.1. Cold piezoelectric plasma device and exposure conditions Plasma device: the piezobrush® PZ2 ( Fig. 1a) from Relyon Plasma GmbH Company is utilized as a cold piezoelectric plasma (CPP) device. This handheld instrument has a low space requirement (about 21 cm length and 4 cm diameter) and is directly plugged into a standard 230 V-socket. This d...

    work page

  5. [5]

    Data availability All datasets generated and analysed during the current study are available from the corresponding authors on reasonable request

    work page

  6. [6]

    Beyrer, M. et al. Cold Atmospheric plasma inactivation of Microbial spores compared on reference surfaces and powder particles. Food Bioprocess. Technol. 13, 827–837 (2020)

    work page 2020

  7. [7]

    Boeckmann, L. et al. Cold atmospheric pressure plasma in wound healing and cancer treatment. Appl. Sci. 10, 6898 (2020)

    work page 2020

  8. [8]

    Dubuc, A. et al. Use of cold-atmospheric plasma in oncology: A concise systematic review. Ther. Adv. Med. Oncol. 10, 1758835918786475 (2018)

    work page 2018

Show all 69 references
  1. [9]

    http://gco.iarc.fr/today/home

    Cancer today. http://gco.iarc.fr/today/home

  2. [10]

    Banales, J. M. et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557–588 (2020)

    2020

  3. [11]

    Van Beers, B. E. Diagnosis of cholangiocarcinoma. HPB 10, 87– 93 (2008)

    2008

  4. [12]

    Olkus, A. et al. Durvalumab Plus Gemcitabine and Cisplatin in patients with advanced biliary Tract Cancer: An exploratory analysis of real-World Data. Target. Oncol. 19, 213–221 (2024)

    2024

  5. [13]

    Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. Cancer J. Clin. 73, 198 –222 (2023)

    2023

  6. [14]

    & Dufour, T

    Judée, F., Vaquero, J., Guégan, S., Fouassier, L. & Dufour, T. Atmospheric pressure plasma jets applied to cancerology: correlating electrical configuration with in vivo toxicity and therapeutic efficiency. J. Phys. D: Appl. Phys. 52, 245201 (2019)

    2019

  7. [15]

    Faramarzi, F. et al. Cold Physical Plasma in Cancer Therapy: Mechanisms, Signaling, and Immunity. Oxidative Medicine and Cellular Longevity e9916796 (2021). (2021)

    2021

  8. [16]

    & Zhu, K

    Dai, X. & Zhu, K. Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting. Cancer Med. 12, 7189–7206 (2023)

    2023

  9. [17]

    Cold Gas Plasma Sources and the Science behind their Applications in Biology and Medicine

    Laroussi, M. Cold Gas Plasma Sources and the Science behind their Applications in Biology and Medicine. Preprint at (2021). https://doi.org/10.48550/arXiv.2106.01366

    2021 doi arXiv

  10. [18]

    Vandamme, M. et al. Antitumor Effect of plasma treatment on U87 glioma xenografts: Preliminary results. Plasma Processes Polym. 7, 264–273 (2010)

    2010

  11. [20]

    Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy

    Bekeschus, S. Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy. Redox Biol. 65, 102798 (2023)

    2023

  12. [21]

    & Boxhammer, V

    Schlegel, J., Köritzer, J. & Boxhammer, V. Plasma in cancer treatment. Clin. Plasma Med. 1, 2–7 (2013)

    2013

  13. [22]

    & Dufour, T

    Decauchy, H., Pavy, A., Camus, M., Fouassier, L. & Dufour, T. Cold plasma endoscopy applied to biliary ducts: feasibility risk assessment on human-like and porcine models for the treatment of cholangiocarcinoma. J. Phys. D: Appl. Phys. 55, 455401 (2022)

    2022

  14. [23]

    Bastin, O. et al. Generation and transport of cold plasma in metres-long tubing for plasma medicine application in endoscopy. (2019)

    2019

  15. [24]

    Winter, J., Nishime, T. M. C., Glitsch, S., Lühder, H. & Weltmann, K. D. On the development of a deployable cold plasma endoscope. Contrib. Plasma Phys. 58, 404–414 (2018)

    2018

  16. [25]

    Hayashi, N., Yao, Y. C. & Matsunaga, Y. Regulation of macrophage-like cell activity driven by atmospheric oxygen plasma. Jpn J. Appl. Phys. 59, SHHF03 (2020)

    2020

  17. [26]

    & Chen, G

    Fang, T., Cao, X., Shen, B., Chen, Z. & Chen, G. Injectable cold atmospheric plasma -activated immunotherapeutic hydrogel for enhanced cancer treatment. Biomaterials 300, 122189 (2023)

    2023

  18. [27]

    Vaquero, J. et al. Cold-Atmospheric plasma induces Tumor Cell death in preclinical in Vivo and in Vitro models of Human Cholangiocarcinoma. Cancers 12, 1280 (2020)

    2020

  19. [28]

    Jones, O. et al. The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro. Sci. Rep. 11, 8967 (2021)

    2021

  20. [29]

    Kniazeva, V. et al. Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride. Front. Oncol. 13 (2023)

    2023

  21. [30]

    González-González, C. R. et al. The effect of cold atmospheric plasma and linalool nanoemulsions against Escherichia coli O157:H7 and Salmonella on ready -to-eat chicken meat. LWT 149, 111898 (2021)

    2021

  22. [31]

    Konchekov, E. M. et al. Properties and Use of Water activated by plasma of Piezoelectric Direct Discharge. Front. Phys. 8, (2021)

    2021

  23. [32]

    Herianto, S. et al. The effects of glazing with plasma-activated water generated by a piezoelectric direct discharge plasma system on whiteleg shrimp (Litopenaeus vannamei). LWT 154, 112547 (2022)

    2022

  24. [33]

    & Nettesheim, S

    Korzec, D., Hoppenthaler, F. & Nettesheim, S. Piezoelectric direct discharge: Devices and applications. Plasma 4, 1–41 (2021)

    2021

  25. [34]

    Artem’ev, K. V. et al. Study of characteristics of the cold atmospheric plasma source based on a Piezo Transformer. Russ Phys. J. 62, 2073–2080 (2020)

    2020

  26. [35]

    & Nettesheim, S

    Korzec, D., Hoppenthaler, F., Burger, D., Andres, T. & Nettesheim, S. Atmospheric pressure plasma jet powered by piezoelectric direct discharge. Plasma Processes Polym. 17, 2000053 (2020)

    2020

  27. [36]

    Timmermann, E. et al. Piezoelectric -driven plasma pen with multiple nozzles used as a medical device: Risk estimation and antimicrobial efficacy. J. Phys. D: Appl. Phys. 54, 025201 (2020)

    2020

  28. [37]

    Stekke, J. et al. Low -voltage plasma Jet with Piezoelectric Generator: Preliminary evaluation of Decontamination Capabilities. IEEE Trans. Plasma Sci. 48, 1264–1270 (2020)

    2020

  29. [38]

    Suzuki-Karasaki, M. et al. Ozone mediates the anticancer effect of air plasma by triggering oxidative cell death caused by H2O2 and iron. Eur. J. Cell Biol. 102, 151346 (2023)

    2023

  30. [39]

    Ferlay, J. et al. Cancer statistics for the year 2020: an overview. Int. J. Cancer. 149, 778–789 (2021)

    2021

  31. [40]

    and analyzed with FIJI software. Immunofluorescence staining: the fixed cells are permeabilized in triton 0.2% for 15 min and incubated in a blocking solution containing PBS with 1% BSA and 10% goat serum for 1 h at RT. Cells are then incubated with the γH2AX antibody solution...

    2024

  32. [41]

    Yon, M. J. Y., Matinlinna, J. P., Tsoi, J. K. H., Vallittu, P. K. & Lassila, L. V. J. plasma treated AR -Glass Fibres in Experimental Reinforced composites with three silanes: A study on Mechanical Properties. Silicon 15, 7109–7119 (2023)

    2023

  33. [42]

    Xu, F. et al. A portable piezoelectric transformer microplasma optical emission spectrometry for the determination of mercury. Microchem. J. 193, 109109 (2023)

    2023

  34. [43]

    & Tan, F

    Wang, Y., Mang, X., Li, X., Cai, Z. & Tan, F. Cold atmospheric plasma induces apoptosis in human colon and lung cancer cells through modulating mitochondrial pathway. Front. Cell. Dev. Biology 10, (2022)

    2022

  35. [44]

    Wang, Y. et al. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF -1α pathway. Free Radic. Biol. Med. 208, 134–152 (2023)

    2023

  36. [45]

    Suzuki-Karasaki, M. et al. Air plasma-activated medium evokes a death -Associated Perinuclear mitochondrial clustering. Int. J. Mol. Sci. 23, 1124 (2022)

    2022

  37. [46]

    & Miklavčič, D

    Batista Napotnik, T., Polajžer, T. & Miklavčič, D. Cell death due to electroporation – a review. Bioelectrochemistry 141, 107871 (2021). This pre-printed document may be used at your convenience although its layout differs from the final published article. 16 Soulier et al., S...

    2021 doi

  38. [47]

    Haralambiev, L. et al. Cold Atmospheric plasma treatment of Chondrosarcoma cells affects proliferation and cell membrane permeability. Int. J. Mol. Sci. 21, 2291 (2020)

    2020

  39. [48]

    & Dufour, T

    Judée, F. & Dufour, T. Plasma gun for medical applications: engineering an equivalent electrical target of human body and deciphering relevant electrical parameters. J. Phys. D: Appl. Phys. 52, 16LT02 (2019)

    2019

  40. [49]

    Chung, T. H. et al. Cell electropermeabilisation enhancement by non-thermal-plasma-treated PBS. Cancers 12, 219 (2020)

    2020

  41. [50]

    H., Yano, K

    Chang, C. H., Yano, K. & Sato, T. Nanosecond pulsed current under plasma -producing conditions induces morphological alterations and stress fiber formation in human fibrosarcoma HT - 1080 cells. Arch. Biochem. Biophys. 681, 108252 (2020)

    2020

  42. [51]

    Konchekov, E. M. et al. Bacterial decontamination of Water - containing objects using Piezoelectric Direct Discharge plasma and plasma jet. Biomolecules 14, 181 (2024)

    2024

  43. [52]

    & Girard, P

    Sklias, K., Santos Sousa, J. & Girard, P. M. Role of short - and long-lived reactive species on the selectivity and anti-cancer action of plasma treatment in Vitro. Cancers 13, 615 (2021)

    2021

  44. [53]

    & Mahendran, R

    Dharini, M., Jaspin, S. & Mahendran, R. Cold plasma reactive species: Generation, properties, and interaction with food biomolecules. Food Chem. 405, 134746 (2023)

    2023

  45. [54]

    Roti Roti, J. L. Cellular responses to hyperthermia (40 –46°C): Cell killing and molecular events. Int. J. Hyperth. 24, 3–15 (2008)

    2008

  46. [55]

    Wu, S. et al. Positive streamer corona, single filament, transient glow, dc glow, spark, and their transitions in atmospheric air. Phys. Plasmas. 25, 123507 (2018)

    2018

  47. [56]

    Jacoby, J. M. et al. An innovative therapeutic option for the treatment of skeletal sarcomas: Elimination of Osteo- and Ewing’s sarcoma cells using Physical Gas plasma. Int. J. Mol. Sci. 21, 4460 (2020)

    2020

  48. [57]

    Nitsch, A. et al. Cold Physical plasma reduces motility of various bone sarcoma cells while remodeling the Cytoskeleton. Vivo 38, 1571–1578 (2024)

    2024

  49. [58]

    Vijayarangan, V. et al. New insights on molecular internalization and drug delivery following plasma jet exposures. Int. J. Pharm. 589, 119874 (2020)

    2020

  50. [59]

    & Mierke, C

    Aermes, C., Hayn, A., Fischer, T. & Mierke, C. T. Cell mechanical properties of human breast carcinoma cells depend on temperature. Sci. Rep. 11, 10771 (2021)

    2021

  51. [60]

    Lobe, C. et al. Zinc finger E-Box binding Homeobox 1 promotes Cholangiocarcinoma Progression through Tumor Dedifferentiation and Tumor –Stroma Paracrine Signaling. Hepatology 74, 3194 (2021)

    2021

  52. [61]

    & Hasse, S

    Schmidt, A., Bekeschus, S., von Woedtke, T. & Hasse, S. Cell migration and adhesion of a human melanoma cell line is decreased by cold plasma treatment. Clin. Plasma Med. 3, 24 –31 (2015)

    2015

  53. [64]

    Freund, E. et al. In Vitro Anticancer Efficacy of six different clinically approved types of liquids exposed to physical plasma. IEEE Trans. Radiation Plasma Med. Sci. 3, 588–596 (2019)

    2019

  54. [65]

    Mitra, S. et al. Impact of ROS generated by Chemical, Physical, and plasma techniques on Cancer Attenuation. Cancers 11, 1030 (2019)

    2019

  55. [66]

    Privat-Maldonado, A. et al. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy. Oxidative Medicine and Cellular Longevity e9062098 (2019). (2019)

    2019

  56. [67]

    Aggarwal, V. et al. Role of reactive oxygen species in Cancer Progression: Molecular mechanisms and recent advancements. Biomolecules 9, 735 (2019). [60 ] Bauer, G. The synergistic effect between hydrogen peroxide and nitrite, two long -lived molecular species from cold atmosp...

    2019

  57. [68]

    Acknowledgements The authors would like to thank Pr. Sophie Thenet, Sorbonne Université, INSERM, Centre de Recherche Saint -Antoine, CRSA; Paris Center for Microbiome Medicine (PaCeMM) FHU, APHP; EPHE, PSL University, Paris, France, for her help in the analysis of cell cyto sk...

  58. [69]

    B.L., methodology; M.S., B.L., T.D and L.F., validation; M.S., I.H

    Author contributions M.S., B.L., T.D and L.F., conceptualization; M.S. B.L., methodology; M.S., B.L., T.D and L.F., validation; M.S., I.H. and B.L., formal analysis; M.S., B.L., I.H., H.D., A.P. and A.C., investigation; T.D, R.M. and L.F., resources; M.S., I.H., B.L. and R.M.,...

  59. [70]

    Competing interests The authors declare no competing interests

  60. [2877]

    Voltage and current are measured on a target mimicking huma n body impedance designed on previous work conducted by Judée et al

    to acquire electric signals. Voltage and current are measured on a target mimicking huma n body impedance designed on previous work conducted by Judée et al. [40]. The target corresponds to a metal plate connected to a derivative circuit constituted by a resistor (RT = 1.5 kΩ)...

    2024

  61. [3054]

    is coupled to a voltage probe (Teledyne LeCroy PP020 10:1) and a current monitor (Pearson Electronics Company, Pearson

Pith tools

Reviewed August 11, 2026 · model on record in the stance chip above.